8.52199
Fmoc-Asp(OtBu)-Thr(psiMe,Mepro)-OH
Novabiochem®
Manufacturer: Sigma Aldrich
CAS Number: 920519-32-0
Synonym(S): Fmoc-Asp(OtBu)-Thr(psiMe,Mepro)-OH
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 G | 8.52199-1-G | In Stock | ₹ 6,729.07 |
| 5 G | 8.52199-5-G | In Stock | ₹ 28,530.00 |
| 8521990025 | 8.52199-8521990025 | In Stock | ₹ 1,31,720.00 |
| 8521990100 | 8.52199-8521990100 | In Stock | ₹ 3,52,750.00 |
8.52199 - 1 G
In Stock
Quantity
1
Base Price: ₹ 6,729.07
GST (18%): ₹ 1,211.233
Total Price: ₹ 7,940.303
Quality Level
200
product line
Novabiochem®
Assay
≥95% (TLC)≥97.0% (HPLC)
form
powder
reaction suitability
reaction type: Fmoc solid-phase peptide synthesis
manufacturer/tradename
Novabiochem®
application(s)
peptide synthesis
functional group
hydroxyl
storage temp.
2-8°C
InChI
1S/C30H36N2O8/c1-17-25(27(35)36)32(30(5,6)39-17)26(34)23(15-24(33)40-29(2,3)4)31-28(37)38-16-22-20-13-9-7-11-18(20)19-12-8-10-14-21(19)22/h7-14,17,22-23,25H,15-16H2,1-6H3,(H,31,37)(H,35,36)/t17-,23+,25+/m1/s1
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | STA PHARMACEUTICAL US LLC WuXi TIDES Fmoc-L-Asp(tBu)-L-Thr[PSI(Me,Me)Pro]-OH | 920519-32-0, 100GR | STA PHARMACEUTICAL US LLC | ₹ 1,51,410.40 | |
| | STA PHARMACEUTICAL US LLC WuXi TIDES Fmoc-L-Asp(tBu)-L-Thr[PSI(Me,Me)Pro]-OH | 920519-32-0, 10GR | STA PHARMACEUTICAL US LLC | ₹ 20,019.33 | |
| | STA PHARMACEUTICAL US LLC WuXi TIDES Fmoc-L-Asp(tBu)-L-Thr[PSI(Me,Me)Pro]-OH | 920519-32-0, 50GR | STA PHARMACEUTICAL US LLC | ₹ 80,566.72 | |
| | STA PHARMACEUTICAL US LLC WuXi TIDES Fmoc-L-Asp(tBu)-L-Thr[PSI(Me,Me)Pro]-OH | 920519-32-0, 25GR | STA PHARMACEUTICAL US LLC | ₹ 44,046.29 | |
 | 920519-32-0 | Fmoc-asp(otbu)-thr(psime,mepro)-oh | A2B Chem | ₹ 3,679.08 - ₹ 26,438.04 |
Related Products
Description
- General description: This pseudoproline dipeptide is undoubtedly the most effective and simplest to use tool for overcoming aggregation and enhancing peptide quality in Fmoc SPPS for peptide containing the Asp-Thr dipeptide motif. It consists of a dipeptide in which the threonine residue has been reversibly protected as a structure-breaking proline-like TFA-labile oxazolidine. The reason the pseudoproline residue is introduced as a dipeptide is because it avoids the need to acylate the hindered oxazolidine nitrogen. This has the added advantage of extending the peptide chain by two residues in one step. The threonine residue is regenerated during the normal TFA-mediated cleavage reaction. Associated Protocols and Technical Articles Cleavage and Deprotection Protocols for Fmoc SPPS Overcoming Aggregation in Fmoc SPPS
- Linkage: Replaces: 05-20-1126
- Analysis Note: Color (visual): white to slight yellow to beigeAppearance of substance (visual): powderIdentity (IR): passes testOptical rotation α 25/D (c=1 in methanol): -23.5 - -18.5 °Purity (TLC(011A)): ≥ 95 %Assay (HPLC, area%): ≥ 97.0 % (a/a)Impurities (single): ≤ 1.00 % (a/a)Ethyl acetate (HS-GC): ≤ 2.0 %Acetate (IC): ≤ 0.1 %To see the solvent systems used for TLC of Novabiochem® products please click here.
- Legal Information: Novabiochem is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFETY INFORMATION
Storage Class Code
11 - Combustible Solids
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
Quality Level: 200
product line: Novabiochem®
Assay: ≥95% (TLC)≥97.0% (HPLC)
form: powder
reaction suitability: reaction type: Fmoc solid-phase peptide synthesis
manufacturer/tradename: Novabiochem®
application(s): peptide synthesis
functional group: hydroxyl
storage temp.: 2-8°C
InChI: 1S/C30H36N2O8/c1-17-25(27(35)36)32(30(5,6)39-17)26(34)23(15-24(33)40-29(2,3)4)31-28(37)38-16-22-20-13-9-7-11-18(20)19-12-8-10-14-21(19)22/h7-14,17,22-23,25H,15-16H2,1-6H3,(H,31,37)(H,35,36)/t17-,23+,25+/m1/s1
Quality Level:
200
product line:
Novabiochem®
Assay:
≥95% (TLC)≥97.0% (HPLC)
form:
powder
reaction suitability:
reaction type: Fmoc solid-phase peptide synthesis
manufacturer/tradename:
Novabiochem®
application(s):
peptide synthesis
functional group:
hydroxyl
storage temp.:
2-8°C
InChI:
1S/C30H36N2O8/c1-17-25(27(35)36)32(30(5,6)39-17)26(34)23(15-24(33)40-29(2,3)4)31-28(37)38-16-22-20-13-9-7-11-18(20)19-12-8-10-14-21(19)22/h7-14,17,22-23,25H,15-16H2,1-6H3,(H,31,37)(H,35,36)/t17-,23+,25+/m1/s1
Quality Level: 200
product line: Novabiochem®
Assay: ≥97% (TLC)≥97.0% (HPLC)
form: powder
reaction suitability: reaction type: Fmoc solid-phase peptide synthesis
manufacturer/tradename: Novabiochem®
application(s): peptide synthesis
functional group: hydroxyl
storage temp.: 2-8°C
InChI: __
Quality Level:
200
product line:
Novabiochem®
Assay:
≥97% (TLC)≥97.0% (HPLC)
form:
powder
reaction suitability:
reaction type: Fmoc solid-phase peptide synthesis
manufacturer/tradename:
Novabiochem®
application(s):
peptide synthesis
functional group:
hydroxyl
storage temp.:
2-8°C
InChI:
__
Quality Level: 200
product line: Novabiochem®
Assay: ≥97% (TLC)≥97.0% (HPLC)
form: powder
reaction suitability: reaction type: Fmoc solid-phase peptide synthesis
manufacturer/tradename: Novabiochem®
application(s): peptide synthesis
functional group: hydroxyl
storage temp.: 2-8°C
InChI: __
Quality Level:
200
product line:
Novabiochem®
Assay:
≥97% (TLC)≥97.0% (HPLC)
form:
powder
reaction suitability:
reaction type: Fmoc solid-phase peptide synthesis
manufacturer/tradename:
Novabiochem®
application(s):
peptide synthesis
functional group:
hydroxyl
storage temp.:
2-8°C
InChI:
__
Quality Level: 200
product line: Novabiochem®
Assay: ≥97% (TLC)≥97.0% (HPLC)
form: powder
reaction suitability: reaction type: Fmoc solid-phase peptide synthesis
manufacturer/tradename: Novabiochem®
application(s): peptide synthesis
functional group: hydroxyl
storage temp.: 2-8°C
InChI: 1S/C37H39N3O8/c1-36(2,3)48-35(45)39-19-22(23-12-10-11-17-30(23)39)18-29(32(41)40-20-31(33(42)43)47-37(40,4)5)38-34(44)46-21-28-26-15-8-6-13-24(26)25-14-7-9-16-27(25)28/h6-17,19,28-29,31H,18,20-21H2,1-5H3,(H,38,44)(H,42,43)/t29-,31-/m0/s1
Quality Level:
200
product line:
Novabiochem®
Assay:
≥97% (TLC)≥97.0% (HPLC)
form:
powder
reaction suitability:
reaction type: Fmoc solid-phase peptide synthesis
manufacturer/tradename:
Novabiochem®
application(s):
peptide synthesis
functional group:
hydroxyl
storage temp.:
2-8°C
InChI:
1S/C37H39N3O8/c1-36(2,3)48-35(45)39-19-22(23-12-10-11-17-30(23)39)18-29(32(41)40-20-31(33(42)43)47-37(40,4)5)38-34(44)46-21-28-26-15-8-6-13-24(26)25-14-7-9-16-27(25)28/h6-17,19,28-29,31H,18,20-21H2,1-5H3,(H,38,44)(H,42,43)/t29-,31-/m0/s1